CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 4 Shares withheld for taxes Chief Operating Officer gave up 32,901 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 100,171 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 32,424 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel gave up 34,638 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 11,552 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel gave up 40,385 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 42,787 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 40,161 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 113,169 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,716 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 6,039 shares (to pay taxes)
- 4 Open-market buy Director bought 1,300,000 shares at an average $10.45 ($13,590,000)
- 4 Open-market sale Chief Medical Officer sold 20,000 shares at $10.50 ($210,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 8,305 shares at $8.23 ($68,350)
Page 2 of 10 · 184 filings